Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / articles / NVO - Obesity In Children - US Parents Face Tough Time To Access Recommended Treatment Though Novo Nordisk's Drug Still Sees Strong Demand | Benzinga


NVO - Obesity In Children - US Parents Face Tough Time To Access Recommended Treatment Though Novo Nordisk's Drug Still Sees Strong Demand | Benzinga

Many U.S. parents seeking help for their child with obesity face challenges accessing the recommended treatment. Leading medical groups advocate for intensive behavioral counseling, requiring 26 hours within a year to teach healthier eating and activity habits.

Also Read: Novo Nordisk Sues Additional US Clinics Against Fake Semaglutide Products Used For Weight Loss, Diabetes.

However, as numerous doctors and parents have noted, these programs are often unavailable, have long waitlists, are not covered by insurance, and require significant time commitments.

The U.S. Centers for Disease Control and Prevention (CDC) revealed that fewer than 1% of the nearly 15 million children with obesity receive such structured care, Reuters reported.

Efforts to expand insurance coverage have stalled. “The coverage for these programs was never good, ...

Full story available on Benzinga.com

Stock Information

Company Name: Novo Nordisk A/S
Stock Symbol: NVO
Market: NYSE
Website: novonordisk.com

Menu

NVO NVO Quote NVO Short NVO News NVO Articles NVO Message Board
Get NVO Alerts

News, Short Squeeze, Breakout and More Instantly...